Tower Research Capital (TRC)’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $119K | Buy |
11,757
+10,913
| +1,293% | +$111K | ﹤0.01% | 2238 |
|
|
2025
Q1 | $4.71K | Sell |
844
-13,817
| -94% | -$77.1K | ﹤0.01% | 4209 |
|
|
2024
Q4 | $118K | Buy |
14,661
+13,384
| +1,048% | +$108K | ﹤0.01% | 2065 |
|
|
2024
Q3 | $13.1K | Sell |
1,277
-3,726
| -74% | -$38.2K | ﹤0.01% | 3542 |
|
|
2024
Q2 | $35.4K | Buy |
5,003
+4,253
| +567% | +$30.1K | ﹤0.01% | 3362 |
|
|
2024
Q1 | $10.3K | Sell |
750
-8,505
| -92% | -$117K | ﹤0.01% | 3713 |
|
|
2023
Q4 | $85.1K | Buy |
9,255
+1,517
| +20% | +$14K | ﹤0.01% | 2761 |
|
|
2023
Q3 | $46.8K | Buy |
7,738
+5,635
| +268% | +$34.1K | ﹤0.01% | 2600 |
|
|
2023
Q2 | $16.3K | Buy |
+2,103
| New | +$16.3K | ﹤0.01% | 3547 |
|
|
2023
Q1 | – | Sell |
-9,077
| Closed | -$53K | – | 6157 |
|
|
2022
Q4 | $53K | Buy |
9,077
+2,110
| +30% | +$12.3K | ﹤0.01% | 2304 |
|
|
2022
Q3 | $22K | Sell |
6,967
-5,126
| -42% | -$16.2K | ﹤0.01% | 3868 |
|
|
2022
Q2 | $55K | Sell |
12,093
-5,437
| -31% | -$24.7K | ﹤0.01% | 2799 |
|
|
2022
Q1 | $94K | Buy |
17,530
+16,717
| +2,056% | +$89.6K | ﹤0.01% | 2250 |
|
|
2021
Q4 | $12K | Sell |
813
-1,697
| -68% | -$25K | ﹤0.01% | 4308 |
|
|
2021
Q3 | $53K | Buy |
2,510
+647
| +35% | +$13.7K | ﹤0.01% | 2921 |
|
|
2021
Q2 | $32K | Buy |
1,863
+311
| +20% | +$5.34K | ﹤0.01% | 3428 |
|
|
2021
Q1 | $38K | Sell |
1,552
-1,083
| -41% | -$26.5K | ﹤0.01% | 3356 |
|
|
2020
Q4 | $89K | Sell |
2,635
-5,093
| -66% | -$172K | ﹤0.01% | 2461 |
|
|
2020
Q3 | $193K | Buy |
7,728
+7,290
| +1,664% | +$182K | ﹤0.01% | 2610 |
|
|
2020
Q2 | $15K | Buy |
+438
| New | +$15K | ﹤0.01% | 3820 |
|